SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001171843-17-003782
Filing Date
2017-06-23
Accepted
2017-06-22 21:30:23
Documents
18
Effectiveness Date
2017-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_062217.htm DEFA14A 34897
2 EXHIBIT 3.6 exh_36.htm EX-3.6 138434
3 EXHIBIT 4.4 exh_44.htm EX-4.4 116855
4 EXHIBIT 4.5 exh_45.htm EX-4.5 49547
5 EXHIBIT 4.6 exh_46.htm EX-4.6 50054
6 EXHIBIT 4.7 exh_47.htm EX-4.7 50196
7 EXHIBIT 4.8 exh_48.htm EX-4.8 50851
8 EXHIBIT 4.9 exh_49.htm EX-4.9 50371
9 EXHIBIT 4.10 exh_410.htm EX-4.10 47885
10 EXHIBIT 4.11 exh_411.htm EX-4.11 50280
11 EXHIBIT 4.12 exh_412.htm EX-4.12 50720
12 EXHIBIT 4.13 exh_413.htm EX-4.13 50687
13 EXHIBIT 4.14 exh_414.htm EX-4.14 52519
14 EXHIBIT 4.15 exh_415.htm EX-4.15 51818
15 EXHIBIT 4.16 exh_416.htm EX-4.16 53284
16 EXHIBIT 4.17 exh_417.htm EX-4.17 50065
17 EXHIBIT 4.18 exh_418.htm EX-4.18 209704
18 EXHIBIT 10.20 exh_1020.htm EX-10.20 649306
  Complete submission text file 0001171843-17-003782.txt   1808455
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36694 | Film No.: 17926236
SIC: 2836 Biological Products, (No Diagnostic Substances)